ArticleCureus2026
Atypical Hemorrhagic Presentation of Neurocysticercosis in a Patient on Chronic Anticoagulation.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system in individuals from endemic regions, but hemorrhagic presentations are rare and may closely mimic neoplastic or vascular lesions, particularly in anticoagulated patients. We describe the case of a 68-year-old woman with a mechanical aortic valve on chronic warfarin therapy who presented with acute confusion and was found to have a left frontal intraparenchymal hemorrhage. Neuroimaging demonstrated a hemorrhagic cystic lesion with an eccentric intracystic nodule suggestive of a scolex, raising concern for NCC despite negative serologic testing. Because serologic assays have limited sensitivity in solitary parenchymal disease, the diagnosis was approached with uncertainty and relied on the characteristic MRI appearance, epidemiologic risk, and the lesion's progressive radiologic regression on follow-up imaging. Management included reversal and temporary suspension of anticoagulation, initiation of albendazole with corticosteroids, seizure prophylaxis, and treatment of hyponatremia, partially pseudohyponatremic due to hyperglycemia but ultimately consistent with syndrome of inappropriate antidiuretic hormone secretion (SIADH). The patient showed gradual clinical improvement and near-complete radiologic resolution over several months. This case underscores the diagnostic challenges of hemorrhagic NCC, the limited sensitivity of serologic assays in solitary parenchymal lesions, and the potential for anticoagulation to amplify hemorrhagic complications. It also highlights the essential role of serial neuroimaging and multidisciplinary management in guiding therapy and avoiding unnecessary surgical intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.